X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10605) 10605
Publication (1305) 1305
Newsletter (679) 679
Book Review (35) 35
Book Chapter (20) 20
Conference Proceeding (12) 12
Dissertation (5) 5
Magazine Article (4) 4
Newspaper Article (4) 4
Book / eBook (3) 3
Data Set (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6364) 6364
animals (6016) 6016
oligopeptides - pharmacology (4832) 4832
male (3991) 3991
index medicus (3739) 3739
female (2562) 2562
rats (2282) 2282
mice (2193) 2193
oligopeptides - chemistry (1728) 1728
oligopeptides (1597) 1597
oligopeptides - metabolism (1591) 1591
amino acid sequence (1502) 1502
pharmacology & pharmacy (1291) 1291
oligopeptides - therapeutic use (1252) 1252
biochemistry & molecular biology (1251) 1251
adult (1243) 1243
peptides (1231) 1231
oligopeptides - administration & dosage (1179) 1179
middle aged (1094) 1094
molecular sequence data (1086) 1086
research (1043) 1043
dose-response relationship, drug (813) 813
cells, cultured (779) 779
expression (742) 742
blood pressure - drug effects (710) 710
hematology (708) 708
kinetics (708) 708
rats, sprague-dawley (699) 699
cell line, tumor (684) 684
time factors (662) 662
immunology (660) 660
cell biology (652) 652
oligopeptides - pharmacokinetics (650) 650
aged (649) 649
analysis (645) 645
proteins (633) 633
in vitro techniques (611) 611
oligopeptides - blood (610) 610
article (607) 607
oligopeptides - chemical synthesis (599) 599
oncology (593) 593
endocrinology & metabolism (577) 577
disease models, animal (554) 554
research article (534) 534
apoptosis (528) 528
cancer (517) 517
cells (504) 504
activation (489) 489
rats, wistar (481) 481
physiology (471) 471
oligopeptides - immunology (469) 469
mice, inbred c57bl (467) 467
peripheral vascular disease (461) 461
protein binding (461) 461
physiological aspects (450) 450
cell line (444) 444
oligopeptides - adverse effects (443) 443
medicine, research & experimental (438) 438
in-vivo (430) 430
in-vitro (427) 427
receptor (419) 419
multidisciplinary sciences (418) 418
treatment outcome (407) 407
health aspects (402) 402
rabbits (402) 402
apoptosis - drug effects (394) 394
medicine (392) 392
peptide (390) 390
structure-activity relationship (386) 386
mice, inbred balb c (368) 368
angiogenesis (358) 358
binding sites (350) 350
atazanavir sulfate (349) 349
ligands (348) 348
inflammation (344) 344
binding (338) 338
therapy (334) 334
neurosciences (330) 330
inhibition (326) 326
dogs (323) 323
drug therapy, combination (318) 318
piperidines - pharmacology (318) 318
oligopeptides - genetics (313) 313
blood platelets - metabolism (312) 312
tissue distribution (299) 299
signal transduction (296) 296
mice, nude (295) 295
platelet aggregation - drug effects (293) 293
care and treatment (289) 289
gene expression (286) 286
infectious diseases (285) 285
integrins (278) 278
receptors (276) 276
protein (273) 273
blood platelets - drug effects (272) 272
peptide fragments - pharmacology (272) 272
rat (272) 272
hypertension (271) 271
substrate specificity (270) 270
hiv infections - drug therapy (267) 267
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10939) 10939
Russian (184) 184
German (57) 57
Chinese (42) 42
Japanese (26) 26
French (21) 21
Spanish (14) 14
Italian (5) 5
Ukrainian (3) 3
Danish (2) 2
Dutch (2) 2
Hungarian (2) 2
Polish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Greek (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 09/2007, Volume 21, Issue 14, pp. 1899 - 1907
Objectives: To describe first dose and steady state antiretroviral drug exposure in the female genital tract. Design: Non-blinded, single center, open-label... 
Women | Genital tract | HIV | Prophylaxis | Sexual transmission | Pharmacokinetics | Antiretroviral therapy | genital tract | INFECTIOUS DISEASES | sexual transmission | antiretroviral therapy | EMTRICITABINE | IMMUNOLOGY | CEREBROSPINAL-FLUID | prophylaxis | BACTERIAL VAGINOSIS | PROTEASE INHIBITOR | TRICHOMONAS-VAGINALIS | HIV-INFECTION | THERAPY | VIROLOGY | LIQUID-CHROMATOGRAPHY | SIMIAN IMMUNODEFICIENCY VIRUS | pharmacokinetics | MACAQUES | women | Lamivudine - administration & dosage | Humans | Deoxycytidine - blood | Zidovudine - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Genitalia, Female - metabolism | Emtricitabine | HIV Infections - blood | HIV Protease Inhibitors - blood | Adenine - analogs & derivatives | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Administration, Oral | Anti-Retroviral Agents - pharmacokinetics | Deoxycytidine - administration & dosage | Lopinavir | HIV Protease Inhibitors - administration & dosage | Adenine - pharmacokinetics | Pyrimidinones - blood | Anti-Retroviral Agents - administration & dosage | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Zidovudine - blood | Deoxycytidine - analogs & derivatives | Reverse Transcriptase Inhibitors - blood | Zidovudine - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Adenine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Adult | Benzoxazines - blood | Female | Organophosphonates - blood | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Oligopeptides - blood | Oligopeptides - pharmacokinetics | Lamivudine - blood | Lamivudine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | HIV Infections - drug therapy
Journal Article
Journal Article
Liver International, ISSN 1478-3223, 07/2015, Volume 35, Issue 7, pp. 1833 - 1844
Background & Aims Chronic infection with HCV remains a public health problem with approximately 150 million people infected worldwide. HCV intersects with... 
HCV protease inhibitor | virological response | apolipoprotein H | biomarker | chronic hepatitis C | Biomarker | Chronic hepatitis C | Apolipoprotein H | Virological response | TELAPREVIR | PARTICLES | REAL-TIME PCR | LOW-DENSITY | HEPATITIS-C VIRUS | IL28B GENOTYPE | GENOTYPE 1 INFECTION | DIRECT-ACTING ANTIVIRALS | BOCEPREVIR | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT FAILURE | Recombinant Proteins - therapeutic use | Predictive Value of Tests | Prospective Studies | Area Under Curve | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Molecular Targeted Therapy | Polyethylene Glycols - therapeutic use | Viral Load | beta 2-Glycoprotein I - blood | Oligopeptides - therapeutic use | Time Factors | Female | Drug Therapy, Combination | France | Protease Inhibitors - therapeutic use | Hepacivirus - drug effects | Virus Replication - drug effects | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Treatment Outcome | Biomarkers - blood | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Proline - therapeutic use | Hepacivirus - enzymology | Hepacivirus - growth & development | ROC Curve | Viral Nonstructural Proteins - metabolism | Aged | Viral Nonstructural Proteins - antagonists & inhibitors | Protease inhibitors | Proteases | Analysis | Liver | Hepatitis C virus | Hepatitis C | Apolipoproteins | Liver cirrhosis | beta 2-Glycoprotein I/blood | Virus Replication/drug effects | Polyethylene Glycols/therapeutic use | Protease Inhibitors/therapeutic use | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Life Sciences | Immunology | Hepacivirus/growth & development | Viral Nonstructural Proteins/antagonists & inhibitors | Biomarkers/blood | Hepatitis C, Chronic/drug therapy | Proline/analogs & derivatives | Hepacivirus/enzymology | Hepacivirus/genetics | Proline/therapeutic use | Viral Nonstructural Proteins/metabolism | Recombinant Proteins/therapeutic use | RNA, Viral/blood | Antiviral Agents/therapeutic use | Oligopeptides/therapeutic use | Hepacivirus/drug effects | Hepatitis C, Chronic/diagnosis | Ribavirin/therapeutic use
Journal Article
American Journal of Physiology - Endocrinology And Metabolism, ISSN 0193-1849, 06/2007, Volume 292, Issue 6, pp. 1616 - 1623
Endothelin-1 (ET-1) is a potent endothelium-derived vasoconstrictor, which also stimulates insulin release. The aim of the present study was to evaluate... 
Blood flow regulation | Endocrine pancreas | Endothelium | ETB RECEPTORS | endothelium | PHYSIOLOGY | endocrine pancreas | RAT | INSULIN-SECRETION | MICROCIRCULATION | ANGIOTENSIN-II | BIG ENDOTHELIN-1 | RELEASE | BLOOD-FLOW | blood flow regulation | ENDOCRINOLOGY & METABOLISM | NITRIC-OXIDE | AFFERENT ARTERIOLES | Arterioles - physiology | Duodenum - blood supply | Endothelin-1 - pharmacology | Male | Peptides, Cyclic - pharmacology | Pancreas - blood supply | Insulin - blood | Regional Blood Flow - drug effects | Piperidines - pharmacology | Endothelin A Receptor Antagonists | Blood Pressure - drug effects | Islets of Langerhans - blood supply | Mice, Inbred C57BL | Vasoconstriction | Rats | Adrenal Glands - blood supply | Endothelin B Receptor Antagonists | Rats, Sprague-Dawley | Colon - blood supply | Drug Synergism | Animals | Mice | Blood Glucose - metabolism | In Vitro Techniques | Oligopeptides - pharmacology | Arterioles/physiology | Endothelin-1/pharmacology | Peptides; Cyclic/pharmacology | Medical and Health Sciences | Medicin och hälsovetenskap | Insulin/blood | MEDICINE | Adrenal Glands/blood supply | Mice; Inbred C57BL | Duodenum/blood supply | Colon/blood supply | Pancreas/blood supply | Blood Glucose/metabolism | Regional Blood Flow/drug effects | Rats; Sprague-Dawley | Receptor; Endothelin B/antagonists & inhibitors | Blood Pressure/drug effects | Receptor; Endothelin A/antagonists & inhibitors | MEDICIN | Islets of Langerhans/blood supply | Oligopeptides/pharmacology | Piperidines/pharmacology
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2003, Volume 9, Issue 7, pp. 907 - 913
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2010, Volume 335, Issue 3, pp. 572 - 579
Biased G protein-coupled receptor ligands engage subsets of the receptor signals normally stimulated by unbiased agonists. However, it is unclear whether... 
PATHWAYS | BIASED LIGANDS | ACTIVATION | INTERNALIZATION | ANTAGONIST | CONTRACTILITY | PHOSPHORYLATION | NITRIC-OXIDE SYNTHASE | KINASE | FUNCTIONAL SELECTIVITY | PHARMACOLOGY & PHARMACY | RNA, Small Interfering - genetics | Humans | Myocardial Contraction - physiology | Myocardial Contraction - drug effects | Arrestins - genetics | Male | Extracellular Signal-Regulated MAP Kinases - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Arrestins - metabolism | Receptor, Angiotensin, Type 1 - genetics | Drug Interactions | Transfection | HEK293 Cells | src-Family Kinases - metabolism | Cardiovascular Physiological Phenomena - drug effects | Ventricular Function, Left - physiology | Blood Pressure - drug effects | Nitric Oxide Synthase Type III - metabolism | Focal Adhesion Kinase 1 - metabolism | Binding, Competitive | Angiotensin II - pharmacology | Angiotensin II - metabolism | Myocytes, Cardiac - cytology | Ventricular Function, Left - drug effects | Rats | Angiotensin II - analogs & derivatives | Oligopeptides - metabolism | Receptor, Angiotensin, Type 1 - agonists | Animals | Myocytes, Cardiac - drug effects | Signal Transduction - drug effects | Proto-Oncogene Proteins c-jun - metabolism | beta-Arrestins | Cell Line, Tumor | Signal Transduction - physiology | Mice | Oligopeptides - pharmacology | GTP-Binding Proteins - metabolism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 22, pp. 2135 - 2142
Journal Article
Journal Article